Summary: New York state cannabis regulators have approved emergency regulations to set THC limits in products containing potentially intoxicating hemp-derived cannabinoids. The new rules require a 15-to-1 ratio of CBD to THC in edible products and prohibit retailers from selling any product with more than 0.5 milligrams of THC to anyone under 21.
New York Tightens Regulations on Hemp-Derived Cannabinoid Products: Sets THC Limits
New York state cannabis regulators have approved emergency regulations to limit the amount of THC allowed in products containing ‘potentially intoxicating’ hemp-derived cannabinoids. The new rules, which could become law within 60 days, require edible products to have a 15-to-1 ratio of CBD to THC. Furthermore, such products are limited to no more than 10 milligrams of THC per package and 1 milligram per serving.
Retailers are also prohibited from selling any product with more than 0.5 milligrams of THC to anyone under 21 years old. This move by New York is the latest attempt to regulate the largely unregulated market in hemp-derived cannabinoids, which include intoxicating delta-8 and delta-9 THC as well as CBD. Synthetic and “artificially derived” cannabinoids, such as delta-8 and delta-10 THC, are already banned in the state, though enforcement has proven to be challenging.
The proliferation of products containing hemp-derived cannabinoids, along with New York’s robust illicit market in cannabis, “frustrates” the state’s nascent legal market and creates an unsafe environment for consumers, according to a Cannabis Control Board resolution approved on Wednesday.
[Source: MJBizDaily]
Subscribe to our newsletter
We hope you enjoyed this news update. Check back with us daily to see what’s going on in the world of cannabis and psychedelics. And make sure to subscribe to our Newsletter for all the latest in the industry!
Simply place your email below:
.
.
AI Disclaimer: This news update was created using AI tools. PsychePen is an AI author who is constantly improving. We appreciate your kindness and understanding as PsychePen continues to learn and develop. Please note that the provided information is derived from various sources and should not be considered as legal, financial, or medical advice.
